Trial Profile
To investigate the association of Alvimopan on gastrointestinal recovery and length of hospitalisation in men undergoing Retroperitoneal lymph node dissection (RPLND) for testicular cancer
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Mar 2017
Price :
$35
*
At a glance
- Drugs Alvimopan (Primary)
- Indications Testicular cancer
- Focus Therapeutic Use
- 23 Mar 2017 New trial record
- 18 Feb 2017 Results presented at the 2017 Genitourinary Cancers Symposium